Valuation: Certara, Inc.

Market Cap 142.78Cr 126.86Cr 118.4Cr 107.92Cr 203.53Cr 14TCr 205.43Cr 1.43TCr 555.23Cr 7.02TCr 536.05Cr 524.42Cr 23TCr P/E 2026 *
-45.4x
P/E 2027 * 999x
Enterprise Value 148.75Cr 132.17Cr 123.36Cr 112.44Cr 212.05Cr 14TCr 214.03Cr 1.49TCr 578.48Cr 7.31TCr 558.5Cr 546.38Cr 23TCr EV / Sales 2026 *
3.92x
EV / Sales 2027 * 3.61x
Free-Float
67.08%
Yield 2026 *
-
Yield 2027 * -
1 day+0.21%
1 week+2.74%
Current month+1.74%
1 month+13.04%
3 months+34.29%
6 months+73.01%
Current year+6.24%
1 week 8.92
Extreme 8.92
9.5
1 month 7.31
Extreme 7.31
9.5
Current year 4.45
Extreme 4.45
10.2
1 year 4.45
Extreme 4.45
13.69
3 years 4.45
Extreme 4.45
19.87
5 years 4.45
Extreme 4.45
45.48
10 years 4.45
Extreme 4.45
45.48
Manager TitleAgeSince
Chief Executive Officer 53 01/01/2026
Director of Finance/CFO 53 15/07/2026
Chief Tech/Sci/R&D Officer - 31/07/2025
Director TitleAgeSince
Chairman 72 01/12/2021
Director/Board Member 68 01/01/2013
Director/Board Member 59 01/08/2017
Date Insider Type Main position Quantity % Market Cap. Importance
01/09/26 Free

Chief Financial Officer

63,532 0.0416%
15/07/26 Other

Chief Financial Officer

1,91,850 0.1233%
01/06/26 Exercice

General Counsel

57,763 0.0371%
Change 5-day change 1-year change 3-year change Capi.($)
+0.21%+2.74%-31.18%-35.00% 142.78Cr
+0.92%+0.26%+0.35%+60.82% 3,84300Cr
-0.68%-0.49%+0.91%+1,088.60% 45TCr
+3.06%+3.79%-50.72%+33.35% 43TCr
+1.76%+7.61%+92.66%+240.62% 33TCr
+1.48%+7.10%+117.42%+537.11% 28TCr
-1.51%-1.08%-20.76%+49.70% 24TCr
-2.45%-0.91%-26.17%+21.01% 14TCr
+1.25%+4.32%+109.70%+208.63% 13TCr
+0.27%+3.39%+82.90%+201.85% 9.95TCr
Average +0.47%+2.19%+27.51%+240.67% 59.46TCr
Weighted average by Cap. +0.20%+0.90%+9.61%+173.66%

Financials

2026 *2027 *
Net sales 38Cr 34Cr 31Cr 29Cr 54Cr 3.65TCr 55Cr 380.99Cr 147.63Cr 1.87TCr 142.54Cr 139.44Cr 5.99TCr 39Cr 35Cr 32Cr 29Cr 56Cr 3.74TCr 56Cr 390.93Cr 151.49Cr 1.91TCr 146.25Cr 143.08Cr 6.14TCr
Net income -2.84Cr -2.52Cr -2.35Cr -2.14Cr -4.04Cr -272.73Cr -4.08Cr -28Cr -11Cr -139.42Cr -11Cr -10Cr -447.45Cr 17.37L 15.44L 14.41L 13.13L 24.77L 17Cr 25L 1.74Cr 67.57L 8.54Cr 65.23L 63.82L 27Cr
Net Debt 5.98Cr 5.31Cr 4.96Cr 4.52Cr 8.52Cr 574.73Cr 8.6Cr 60Cr 23Cr 293.81Cr 22Cr 22Cr 942.94Cr -1.99Cr -1.77Cr -1.65Cr -1.51Cr -2.84Cr -191.52Cr -2.87Cr -20Cr -7.75Cr -98Cr -7.48Cr -7.32Cr -314.21Cr
Logo Certara, Inc.
Certara, Inc. is a provider of biosimulation science, technology, and consulting services for using Model-Informed Drug Development (MIDD) in the global biopharmaceutical and biotech industry. The Company's proprietary biosimulation platforms are built on biology, chemistry, and pharmacology principles with proprietary mathematical algorithms that model how medicines and diseases behave in the body. It has developed scientifically-based solutions for the collection, standardization, validation, storage, and analysis of the preclinical, clinical and evidence data needed for MIDD. These data solutions are used internally and industry-wide by life sciences companies. The Company applies AI capabilities within established modeling environments and under the supervision of experienced scientists and regulatory experts. Its modeling platforms and curated datasets position it to incorporate emerging AI techniques in a controlled and scientifically rigorous manner.
Employees
1,546
Date Price Change Volume
02/26/02 $9.360 +0.21% 26,45,999
01/26/01 $9.340 +1.52% 38,56,086
30/26/30 $9.200 -0.65% 34,17,705
29/26/29 $9.260 +1.42% 29,36,290
28/26/28 $9.130 +0.22% 29,43,636
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
13
Last Close Price
9.360USD
Average target price
8.486USD
Spread / Average Target
-9.33%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CERT Stock